[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@Amylucio2009](/creator/twitter/Amylucio2009) "$bcab Early data: EpCAM TCE shows high DCR 5/7 pts overall incl. 2/2 @1.2 mg with tumor shrinkage. Still early but DCR looks on par with HER2 TCE from $VIR (1040 mg) and better than EGFR TCE CX904 from CTMX (DCR 25%)" [X Link](https://x.com/Amylucio2009/status/1980034658105717061) [@Amylucio2009](/creator/x/Amylucio2009) 2025-10-19T22:13Z 1371 followers, 3610 engagements "@oncinvestor @1 X PR observed at XXX mg already exceeds my expectations. The next 1-2 data updates will be interesting to watch. For tarlatamab a PR was seen at XXX mg with maximal responses achieved between 3100 mg. $bcab" [X Link](https://x.com/Amylucio2009/status/1980149865322840502) [@Amylucio2009](/creator/x/Amylucio2009) 2025-10-20T05:51Z 1371 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Amylucio2009
"$bcab Early data: EpCAM TCE shows high DCR 5/7 pts overall incl. 2/2 @1.2 mg with tumor shrinkage. Still early but DCR looks on par with HER2 TCE from $VIR (1040 mg) and better than EGFR TCE CX904 from CTMX (DCR 25%)"
X Link @Amylucio2009 2025-10-19T22:13Z 1371 followers, 3610 engagements
"@oncinvestor @1 X PR observed at XXX mg already exceeds my expectations. The next 1-2 data updates will be interesting to watch. For tarlatamab a PR was seen at XXX mg with maximal responses achieved between 3100 mg. $bcab"
X Link @Amylucio2009 2025-10-20T05:51Z 1371 followers, XXX engagements
/creator/twitter::264383884/posts